Biogen Joins With Alnylam On RNAi Therapies For PML.
Therapeutics Daily (subscription) (press release) - Newtown,PA,USA
... targeting progressive multifocal leukoencephalopathy (PML), a brain infection linked in rare cases to the use of Biogen's multiple sclerosis drug Tysabri. ...

---

A possible advance in fight against multiple sclerosis
SouthCoastToday.com - New Bedford,MA,USA
... possible to protect people with multiple sclerosis from long ... Harvard Medical School, worked with mice that had ... nicotinamide— a form of vitamin B3, or niacin ...

Vitamin hope for multiple-sclerosis treatment
New Scientist (subscription) - UK
... damage in mice suffering from a multiple sclerosis-like illness, a new study reveals. As a result, the researchers hope that a form of vitamin B3 (nicotinamide ...